Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (404) 404
primary ovarian insufficiency - chemically induced (363) 363
humans (339) 339
science & technology (323) 323
life sciences & biomedicine (314) 314
adult (193) 193
antineoplastic agents - adverse effects (130) 130
chemotherapy (130) 130
animals (123) 123
obstetrics & gynecology (114) 114
primary ovarian insufficiency - prevention & control (109) 109
pregnancy (102) 102
ovary - drug effects (94) 94
biological and medical sciences (87) 87
cancer (84) 84
medical sciences (80) 80
breast neoplasms - drug therapy (77) 77
oncology (76) 76
antineoplastic combined chemotherapy protocols - adverse effects (64) 64
mice (63) 63
adolescent (62) 62
middle aged (62) 62
cyclophosphamide - adverse effects (60) 60
reproductive biology (60) 60
breast cancer (59) 59
infertility, female - chemically induced (58) 58
premature ovarian failure (57) 57
follicle stimulating hormone - blood (49) 49
disease models, animal (47) 47
risk factors (46) 46
cryopreservation (44) 44
abridged index medicus (42) 42
estradiol - blood (42) 42
primary ovarian insufficiency - drug therapy (41) 41
fertility preservation (40) 40
menopause (40) 40
primary ovarian insufficiency - blood (40) 40
cyclophosphamide (39) 39
infertility, female - prevention & control (39) 39
ovarian follicle - drug effects (39) 39
fertility (38) 38
gynecology. andrology. obstetrics (38) 38
treatment outcome (38) 38
amenorrhea - chemically induced (37) 37
gonadotropin-releasing hormone - agonists (37) 37
primary ovarian insufficiency - pathology (36) 36
rats (36) 36
fertility preservation - methods (35) 35
cyclophosphamide - administration & dosage (34) 34
primary ovarian insufficiency - therapy (34) 34
anti-mullerian hormone - blood (33) 33
antineoplastic agents - therapeutic use (33) 33
neoplasms - drug therapy (33) 33
primary ovarian insufficiency - metabolism (33) 33
apoptosis (32) 32
obstetrics and gynecology (32) 32
young adult (32) 32
antineoplastic combined chemotherapy protocols - therapeutic use (31) 31
care and treatment (31) 31
male (31) 31
ovary - pathology (31) 31
research (31) 31
endocrinology & metabolism (30) 30
hodgkin disease - drug therapy (30) 30
health aspects (29) 29
ovary (29) 29
ovary - transplantation (29) 29
primary ovarian insufficiency - physiopathology (29) 29
child (28) 28
fertility - drug effects (28) 28
infertility (28) 28
transplantation (28) 28
tumors (28) 28
age factors (27) 27
ovary - metabolism (27) 27
prospective studies (27) 27
stem cells (27) 27
endocrine system (26) 26
luteinizing hormone - blood (26) 26
medicine & public health (26) 26
mice, inbred c57bl (26) 26
ovarian failure (26) 26
pharmacology. drug treatments (26) 26
premenopause (26) 26
survivors (26) 26
general & internal medicine (25) 25
gonadotropin-releasing hormone - analogs & derivatives (25) 25
internal medicine (25) 25
medicine, general & internal (25) 25
ovary - physiopathology (25) 25
primary ovarian insufficiency - etiology (25) 25
retrospective studies (24) 24
ovary - physiology (23) 23
gonadotropin-releasing hormone - therapeutic use (22) 22
follow-up studies (21) 21
time factors (21) 21
apoptosis - drug effects (20) 20
cohort studies (20) 20
medicine (20) 20
medicine, research & experimental (20) 20
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (388) 388
French (11) 11
Chinese (8) 8
Czech (3) 3
Spanish (3) 3
German (2) 2
Japanese (2) 2
Dutch (1) 1
Italian (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Primary ovarian insufficiency
by De Vos, Michel, Prof and Devroey, Paul, Prof and Fauser, Bart CJM, Prof
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9744, pp. 911 - 921
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Estradiol - blood | Estrogen Replacement Therapy | Risk Assessment | Humans | Risk Factors | Primary Ovarian Insufficiency - psychology | Primary Ovarian Insufficiency - chemically induced | Primary Ovarian Insufficiency - therapy | Reproduction | Animals | Antineoplastic Agents - adverse effects | Primary Ovarian Insufficiency - diagnosis | Follicle Stimulating Hormone - blood | Infertility, Female - etiology | Female | Primary Ovarian Insufficiency - physiopathology | Primary Ovarian Insufficiency - etiology | Reproductive Medicine | Disease Models, Animal | Ovarian diseases | Development and progression | Follicle-stimulating hormone | Health aspects | Risk factors | Estrogen | Health risk assessment | Womens health | Cancer therapies | Mortality | Menopause | Cancer | Index Medicus | Abridged Index Medicus | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Dehydroepiandrosterone supplementation attenuates ovarian ageing in a galactose-induced primary ovarian insufficiency rat model
by Sozen, Berna and Ozekinci, Murat and Erman, Munire and Gunduz, Tonguc and Demir, Necdet and Akouri, Randa and Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi and Sahlgrenska akademin and Göteborgs universitet and Gothenburg University and Institute of Clinical Sciences, Department of Obstetrics and Gynecology and Sahlgrenska Academy
Journal of assisted reproduction and genetics, ISSN 1058-0468, 10/2019, Volume 36, Issue 10, pp. 2181 - 2189
Human Genetics | DHEA | Medicine & Public Health | Rat | Gynecology | Primary ovarian insufficiency | Reproductive Medicine | Galactosemia | Genetics & Heredity | Life Sciences & Biomedicine | Obstetrics & Gynecology | Reproductive Biology | Science & Technology | Dehydroepiandrosterone - pharmacology | Primary Ovarian Insufficiency - pathology | Humans | Aging - drug effects | Rats | Galactosemias - pathology | Primary Ovarian Insufficiency - chemically induced | Pregnancy | Ovarian Follicle - drug effects | Animals | Aging - genetics | Galactosemias - chemically induced | Female | Galactose - toxicity | Ovarian Follicle - pathology | Dietary Supplements | Primary Ovarian Insufficiency - diet therapy | Disease Models, Animal | Galactosemias - complications | Galactosemias - diet therapy | Immunohistochemistry | Weaning | Dietary supplements | Caspase | Ovaries | Caspase-3 | Progeny | Dehydroepiandrosterone | Cell death | Fertility | Rodents | Aging | Supplementation | Galactose | Apoptosis | Index Medicus | Reproductive Physiology and Disease | Medicinsk genetik | Medical Genetics | Obstetrics, Gynecology and Reproductive Medicine | Reproduktionsmedicin och gynekologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study
by Badawy, Ahmed, M.D and Elnashar, Aboubakr, M.D and El-Ashry, Mohamed, M.D and Shahat, May, M.D
Fertility and sterility, ISSN 0015-0282, 2009, Volume 91, Issue 3, pp. 694 - 697
Internal Medicine | Obstetrics and Gynecology | chemotherapy | ovarian function | GnRHa | Life Sciences & Biomedicine | Obstetrics & Gynecology | Reproductive Biology | Science & Technology | Gynecology. Andrology. Obstetrics | Biological and medical sciences | Medical sciences | Estradiol - blood | Lymph Node Excision | Breast Neoplasms - surgery | Prospective Studies | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Progesterone - blood | Menstruation - drug effects | Time Factors | Infertility, Female - chemically induced | Mastectomy | Adult | Female | Ovary - drug effects | Ovulation - drug effects | Chemotherapy, Adjuvant | Fertility Agents, Female - administration & dosage | Gonadotropin-Releasing Hormone - agonists | Amenorrhea - chemically induced | Goserelin - administration & dosage | Drug Administration Schedule | Luteinizing Hormone - blood | Treatment Outcome | Follicle Stimulating Hormone, Human - blood | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Primary Ovarian Insufficiency - chemically induced | Infertility, Female - physiopathology | Amenorrhea - prevention & control | Infertility, Female - prevention & control | Primary Ovarian Insufficiency - prevention & control | Adenocarcinoma - surgery | Ovary - physiopathology | Chemotherapy | Hormones | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy
by Dillon, Katherine E., B.A and Sammel, Mary D., Sc.D and Prewitt, Maureen, R.N and Ginsberg, Jill P., M.D and Walker, Dana, M.D., M.S.C.E and Mersereau, Jennifer E., M.D., M.S.C.I and Gosiengfiao, Yasmin, M.D and Gracia, Clarisa R., M.D., M.S.C.E
Fertility and sterility, ISSN 0015-0282, 2013, Volume 99, Issue 2, pp. 477 - 483.e1
Internal Medicine | Obstetrics and Gynecology | gonadotoxicity | Chemotherapy | ovarian reserve | young adults | fertility | Life Sciences & Biomedicine | Obstetrics & Gynecology | Reproductive Biology | Science & Technology | Humans | Infertility, Female - blood | Recovery of Function | Primary Ovarian Insufficiency - blood | Primary Ovarian Insufficiency - chemically induced | Young Adult | Antineoplastic Agents - adverse effects | Adolescent | Infertility, Female - chemically induced | Adult | Female | Primary Ovarian Insufficiency - physiopathology | Anti-Mullerian Hormone - blood | Medical colleges | Transplantation | Hormones | Stem cells | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Adjuvant gonadotropin‐releasing hormone analogues for the prevention of chemotherapy‐induced premature ovarian failure in premenopausal women
by Chen, Hengxi and Xiao, Li and Li, Jinke and Cui, Lin and Huang, Wei and Huang, Wei
Cochrane library, ISSN 1469-493X, 03/2019, Volume 2019, Issue 4, pp. CD008018 - CD008018
'ORPHAN' TOPICS CURRENTLY BEING ADDRESSED | Menstruation | Premenopause | Antineoplastic Agents | Techniques to modulate the effects of chemotherapy and/or radiotherapy | Injections, Intramuscular | Administration, Intranasal | Ovulation | Recovery of Function | Randomized Controlled Trials as Topic | Ovary | Gynaecological | Injections, Subcutaneous | Primary Ovarian Insufficiency | Gonadotropin‐Releasing Hormone | Techniques to modulate the effects of chemotherapy & radiotherapy | Medicine General & Introductory Medical Sciences | Pregnancy Rate | General cancer treatments | Cancer | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recovery of Function - drug effects | Humans | Middle Aged | Gonadotropin-Releasing Hormone - analogs & derivatives | Primary Ovarian Insufficiency - chemically induced | Pregnancy | Young Adult | Menstruation - drug effects | Antineoplastic Agents - adverse effects | Adolescent | Adult | Female | Primary Ovarian Insufficiency - prevention & control | Ovulation - drug effects | Child | Gonadotropin-Releasing Hormone - agonists | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Accelerated Ovarian Failure: A novel, chemically induced animal model of menopause
by Van Kempen, Tracey A and Milner, Teresa A and Waters, Elizabeth M
Brain research, ISSN 0006-8993, 2011, Volume 1379, pp. 176 - 187
Neurology | Perimenopause | Hormone replacement therapy | Estrogen | Fundamental and applied biological sciences. Psychology | Hormones. Endocrine system | Hormone metabolism and regulation | Vertebrates: reproduction | Mammalian female genital system | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Primary Ovarian Insufficiency - metabolism | Vinyl Compounds - toxicity | Postmenopause - drug effects | Ovariectomy | Humans | Cyclohexenes - toxicity | Primary Ovarian Insufficiency - chemically induced | Animals | Menopause - metabolism | Postmenopause - metabolism | Menopause - drug effects | Time Factors | Female | Models, Animal | Index Medicus | hormone replacement therapy | perimenopause | estrogen
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies
by Lambertini, M and Ceppi, M and Poggio, F and Peccatori, F.A and Azim, H.A and Ugolini, D and Pronzato, P and Loibl, S and Moore, H.C.F and Partridge, A.H and Bruzzi, P and Del Mastro, L
Annals of oncology, ISSN 0923-7534, 12/2015, Volume 26, Issue 12, pp. 2408 - 2419
premenopausal patients | breast cancer | fertility preservation | luteinizing hormone-releasing hormone agonists | ovarian function preservation | Life Sciences & Biomedicine | Oncology | Science & Technology | Primary Ovarian Insufficiency - metabolism | Randomized Controlled Trials as Topic - methods | Humans | Primary Ovarian Insufficiency - drug therapy | Fertility - physiology | Primary Ovarian Insufficiency - chemically induced | Pregnancy | Antineoplastic Agents, Hormonal - adverse effects | Gonadotropin-Releasing Hormone - metabolism | Fertility - drug effects | Female | Ovary - drug effects | Gonadotropin-Releasing Hormone - agonists | Ovary - metabolism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Huyang yangkun formula protects against 4-Vinylcyclohexene diepoxide-induced premature ovarian insufficiency in rats via the Hippo–JAK2/STAT3 signaling pathway
by Xie, Li and Wu, Sining and Cao, Dongdong and Li, Meifang and Liu, Jian and Nie, Guangning and Li, Yang and Yang, Hongyan
Biomedicine & pharmacotherapy, ISSN 0753-3322, 08/2019, Volume 116, pp. 109008 - 109008
RNA-seq analysis | Premature ovarian insufficiency (POI) | Hippo pathway | Huyang yangkun formula (HYF) | JAK2/STAT3 pathway | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Liver - pathology | Kidney - pathology | Cyclohexenes | Drugs, Chinese Herbal - pharmacology | Protective Agents - therapeutic use | Ovarian Follicle - drug effects | Reference Standards | Liver - drug effects | Protective Agents - pharmacology | Janus Kinase 2 - metabolism | Female | Anti-Mullerian Hormone - blood | Drugs, Chinese Herbal - therapeutic use | Gene Ontology | Protein-Serine-Threonine Kinases - metabolism | STAT3 Transcription Factor - metabolism | Disease Models, Animal | Kidney - drug effects | Signal Transduction | Vinyl Compounds | Primary Ovarian Insufficiency - drug therapy | Rats, Sprague-Dawley | Primary Ovarian Insufficiency - blood | Primary Ovarian Insufficiency - chemically induced | Animals | Models, Biological | Primary Ovarian Insufficiency - genetics | Ovarian Follicle - pathology | Cluster Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights